Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Pubmed

Mutagenesis of diploid mammalian genes by gene entrapment.

CTC1 IGLL5 PTDSS2

1.60e-0512514317062627
Pubmed

Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

RNF25 USP20

5.65e-052814222118674
CytobandEnsembl 112 genes in cytogenetic band chr9q34

AJM1 USP20

4.30e-03325142chr9q34
ToppCellfacs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DISP3 AJM1 NRXN3

1.14e-05144143e9d62f202f0fa8747961036ef0eafed91fe8a42f
ToppCellTCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-2|TCGA-Endometrium / Sample_Type by Project: Shred V9

IDUA ABCA7 PTDSS2

2.08e-05176143179b1778e8f6c4cd777cec971960211e7ba5d84a
DrugMethotrexate [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A

IDUA CTC1 ABCA7

1.86e-041871435419_UP
DrugIvermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A

CTC1 ABCA7 NRXN3

1.92e-041891437206_UP
DrugHyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A

IDUA ABCA7 USP20

2.01e-041921432271_DN
Drugtroglitazone; Down 200; 10uM; HL60; HT_HG-U133A

RNF25 IGLL5 ABCA7

2.10e-041951436191_DN
DrugEtofylline [519-37-9]; Up 200; 17.8uM; HL60; HG-U133A

RNF25 PTDSS2 USP20

2.10e-041951431409_UP
DrugFamotidine [76824-35-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A

IDUA PTDSS2 USP20

2.13e-041961435011_DN
DrugCisapride [81098-60-4]; Down 200; 8.6uM; HL60; HT_HG-U133A

CTC1 PTDSS2 USP20

2.13e-041961432443_DN
DrugPiribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A

CTC1 ABCA7 USP20

2.13e-041961432951_UP
DrugAzathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A

IDUA CTC1 ABCA7

2.16e-041971431528_UP
DrugIndapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A

RNF25 ABCA7 USP20

2.16e-041971433859_UP
DrugMetronidazole [443-48-1]; Down 200; 23.4uM; PC3; HT_HG-U133A

CTC1 ABCA7 NRXN3

2.20e-041981434023_DN
DrugNeomycin sulfate [1405-10-3]; Up 200; 4.2uM; PC3; HT_HG-U133A

CTC1 ABCA7 NRXN3

2.20e-041981435867_UP
DrugTubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; PC3; HT_HG-U133A

ABCA7 PTDSS2 NRXN3

2.20e-041981436351_UP
DrugCefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A

CTC1 ABCA7 PTDSS2

2.23e-041991434390_DN
DiseaseAlzheimer disease

IDUA ABCA7 NRXN3

6.60e-04485113MONDO_0004975
Diseasehip bone mineral density

IDUA NRXN3

9.70e-04126112EFO_0007702
Diseasetelomere length

CTC1 NRXN3

5.79e-03313112EFO_0004505
Diseasehip circumference

ELAPOR2 NRXN3

6.72e-03338112EFO_0005093

Protein segments in the cluster

PeptideGeneStartEntry
WRHWPLASRPPASGF

DISP3

46

Q9P2K9
PRWSYLPPARWNSSG

CTC1

161

Q2NKJ3
RSSPAWADWGPRPYR

AJM1

396

C9J069
IPEPWNFPFRRSYWC

ABCA7

761

Q8IZY2
RGSLWRFGDVPWPCP

NFKBIL1

291

Q9UBC1
PRRGRSPPWSPAWIC

ELAPOR2

21

A8MWY0
PQRADPRCWPRGFWS

IGLL5

76

B9A064
PRCWPRGFWSEPQSL

IGLL5

81

B9A064
WPLRRFWRSTGFCPP

IDUA

41

P35475
DWTHPLPWGRPRTFS

RTKN

506

Q9BST9
PPRRPAWTLGIWFLF

NRXN3

11

Q9HDB5
PFSRPHPAYWRFWLC

PTDSS2

116

Q9BVG9
RPSPYWRLTWRVVSP

SLC6A18

511

Q96N87
WQGPPPRRTRDCVRW

RNF25

406

Q96BH1
RRFVVSCTPSWFWGP

USP20

521

Q9Y2K6